VR Logo

GeoVax Labs Inc. (GOVX) download report


Healthcare | Biotechnology & Pharma Research

GeoVax Labs Inc. (GOVX) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform.

IPO Date: 09-Apr-1999

Chairman, Pres & CEO: Mr. David Alan Dodd

CFO & Corp. Sec.: Mr. Mark W. Reynolds CPA, CPA

Listing: NASDAQ: GOVX

Country: United States

Headquarters: Smyrna, GA

Website: https://www.geovax.com

Key Facts

Market cap: $40.40 Mln

Revenue (TTM): $0.36 Mln

Earnings (TTM): $-19.44 Mln

Cash: $16.26 Mln

Total Debt: $0.00 Mln

Insider's Holding: 2.21%

Liquidity: Low

52 Week range: $0.55 - 7.50

Shares outstanding: 12,547,800

10 Years Aggregate:

  • CFO: $-29.61 Mln
  • EBITDA: $-41.24 Mln
  • Net Profit: $-41.74 Mln

Stock Performance

Time Period GeoVax Labs (GOVX) S&P BSE Sensex* S&P Small-Cap 600*
YTD-11.050.84-11.58
1 month297.538.428.86
3 months318.187.12-2.19
1 Year-23.708.23-6.23
3 Years-90.7016.999.73
5 Years-91.5612.737.72
10 Years-71.7712.8110.81
As on 05-Aug-2022 *As on 08-Aug-2022
Year GeoVax Labs (GOVX) S&P Small-Cap 600 S&P BSE Sensex
20217.1025.2721.99
2020-71.839.5715.75
2019-100.0020.8614.38
2018-51.81-9.705.87
20170.0011.7327.91
20160.0024.741.95
20150.00-3.36-5.03